GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio, Inc. (ANVS) | 8/14/2026 4:51:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $22,037,091 | EPS -$0.40 | ||
| Annovis Bio, Inc. (ANVS) | 8/14/2026 4:12:10 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $22,037,091 | EPS -$0.40 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 5/15/2026 4:45:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $16,243,703 | EPS -$0.63 | ||
| Annovis Bio, Inc. (ANVS) | 5/15/2026 4:02:46 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $16,243,703 | EPS -$0.63 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 4/30/2026 6:41:12 PM | View | Proxy | SEC | Y 2025 | ||||||
| Annovis Bio, Inc. (ANVS) | 3/16/2026 5:06:56 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $21,081,625 | EPS -$0.39 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 3/13/2026 5:25:16 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $21,081,625 | EPS -$1.40 | ||
| Annovis Bio, Inc. (ANVS) | 11/13/2025 6:01:25 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $17,188,961 | EPS -$0.37 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 11/12/2025 4:22:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $17,188,961 | EPS -$0.37 | ||
| Annovis Bio, Inc. (ANVS) | 8/12/2025 4:45:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $21,454,571 | EPS -$0.32 | ||
| Annovis Bio, Inc. (ANVS) | 8/12/2025 4:20:26 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $21,454,571 | EPS -$0.32 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 5/13/2025 4:44:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $26,737,253 | EPS -$0.32 | ||
| Annovis Bio, Inc. (ANVS) | 5/13/2025 4:41:50 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $26,737,253 | EPS -$0.32 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 4/30/2025 6:04:55 PM | View | Proxy | SEC | Y 2024 | ||||||
| Annovis Bio, Inc. (ANVS) | 3/21/2025 5:22:28 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $13,925,633 | EPS -$2.31 | ||
| Annovis Bio, Inc. (ANVS) | 3/21/2025 5:12:24 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $13,925,633 | EPS -$0.42 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 11/12/2024 9:20:05 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $14,361,576 | EPS -$0.97 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 11/8/2024 5:20:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $14,361,576 | EPS -$0.97 | ||
| Annovis Bio, Inc. (ANVS) | 8/15/2024 7:16:45 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $5,046,455 | EPS -$0.44 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 8/14/2024 4:20:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $5,046,455 | EPS -$0.44 | ||
| Annovis Bio, Inc. (ANVS) | 5/13/2024 4:07:13 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $7,813,295 | EPS -$0.72 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 5/10/2024 5:27:24 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $7,813,295 | EPS -$0.72 | ||
| Annovis Bio, Inc. (ANVS) | 4/29/2024 5:24:47 PM | View | Proxy | SEC | Y 2023 | ||||||
| Annovis Bio, Inc. (ANVS) | 4/3/2024 6:02:53 AM | View | Conf. Call | SEC | 1Q 2024 | ||||||
| Annovis Bio, Inc. (ANVS) | 3/29/2024 5:27:42 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $10,208,264 | EPS -$6.23 | ||
| Annovis Bio, Inc. (ANVS) | 11/8/2023 5:01:54 PM | View | Financials | Earnings | WIRE | 3Q 2023 | Assets $10,223,106 | EPS -$1.63 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 11/8/2023 4:55:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $10,223,106 | EPS -$1.63 | ||
| Annovis Bio, Inc. (ANVS) | 8/15/2023 7:26:32 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $22,816,484 | EPS -$1.07 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 8/14/2023 4:56:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $22,816,484 | EPS -$1.07 | ||
| Annovis Bio, Inc. (ANVS) | 5/11/2023 7:02:43 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $25,547,363 | EPS -$1.07 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 5/10/2023 4:42:05 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $25,547,363 | EPS -$1.07 | ||
| Annovis Bio, Inc. (ANVS) | 4/28/2023 8:01:41 AM | View | Proxy | SEC | Y 2022 | ||||||
| Annovis Bio, Inc. (ANVS) | 4/3/2023 7:53:28 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $36,022,069 | EPS -$0.94 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 3/31/2023 5:09:28 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $36,022,069 | EPS -$3.10 | ||
| Annovis Bio, Inc. (ANVS) | 11/8/2022 5:36:12 PM | View | Financials | Earnings | WIRE | 3Q 2022 | Assets $37,118,428 | EPS -$0.79 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 11/8/2022 4:57:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $37,118,428 | EPS -$0.79 | ||
| Annovis Bio, Inc. (ANVS) | 8/8/2022 11:57:35 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $39,967,218 | EPS -$0.73 | ||
| Annovis Bio, Inc. (ANVS) | 8/8/2022 8:31:36 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $39,967,218 | EPS -$0.73 | Export Earnings Model | ||
| Annovis Bio, Inc. (ANVS) | 5/4/2022 11:59:04 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $44,097,580 | EPS -$0.64 | ||
| Annovis Bio, Inc. (ANVS) | 4/18/2022 4:11:43 PM | View | Proxy | SEC | Y 2021 | ||||||
| Annovis Bio, Inc. (ANVS) | 3/2/2022 4:23:31 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $46,001,478 | EPS -$1.90 | ||
| Annovis Bio, Inc. (ANVS) | 11/3/2021 10:03:35 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $47,650,490 | EPS -$0.35 | ||
| Annovis Bio, Inc. (ANVS) | 7/28/2021 4:02:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $49,496,238 | EPS -$0.34 | ||
| Annovis Bio, Inc. (ANVS) | 5/6/2021 1:03:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $5,964,956 | EPS -$0.46 | ||
| Annovis Bio, Inc. (ANVS) | 4/19/2021 2:05:55 PM | View | Proxy | SEC | Y 2020 | ||||||
| Annovis Bio, Inc. (ANVS) | 3/3/2021 11:52:47 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $8,119,334 | EPS -$0.87 | ||
| Annovis Bio, Inc. (ANVS) | 11/4/2020 11:47:46 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $9,402,001 | EPS -$0.15 | ||
| Annovis Bio, Inc. (ANVS) | 7/29/2020 10:55:41 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $10,201,216 | EPS -$0.34 | ||
| Annovis Bio, Inc. (ANVS) | 5/5/2020 9:45:01 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $11,441,186 | EPS -$0.10 | ||
| Annovis Bio, Inc. (ANVS) | 4/24/2020 12:26:21 PM | View | Proxy | SEC |